About
Your life changer. Biomie
We work with characterised strains, clinically-studied actives and a formulation discipline borrowed from pharmaceuticals — not from supplements. Biomie is the everyday expression of that library: living strains in simple regimens, built to be the easiest pill of your day.
Daily Premium in 30- and 60-capsule packs, Biomie® SOS for acute upset and travel, and Biomie® Kids — a powder synbiotic for children from six months. Every formula is protected by an acid-resistant DRcaps® capsule or delivered in a single daily sachet.
Adults and children who want microbiome support without a regimen to manage. One capsule or one sachet a day, no refrigeration, free from gluten, lactose and added sugars.
About
Your life changer. Pro Biomie
Pro Biomie takes the same reference library into clinical territory: higher-strength formulations for specific conditions — gastric, urinary, inflammatory — co-developed with clinicians and dosed to match the published evidence.
Pro Biomie® Urobiotic leads the line: a four-part synergy of clinical-dose D-mannose, cranberry proanthocyanidins, targeted probiotics and vitamin D3 in one daily sachet. Further condition-specific formulations are in development.
Patients working with a clinician on a specific condition, and the practitioners who recommend them. Clinical doses, named actives and a full composition you can hand to a specialist.
About
Your life changer. Inflomega
Inflomega is our flagship anti-inflammatory programme — postbiotic-derived, omega-stabilised, mechanism-led. It is the part of the library where we go deepest: the mechanism comes first and the formulation follows it.
The programme is in active development. Formulations are moving through pre-clinical and clinical work now, and the first Inflomega products will join the catalogue as those studies read out.
People living with chronic, low-grade inflammation — and the clinicians and researchers who want to see the mechanism before the marketing.
Products
Learn what we got
A cross-section of where our work stands today. Living data — updated as new trials, strains and markets come online.
Numbers
The science in numbers.
A cross-section of where our work stands today. Living data — updated as new trials, strains and markets come online.
120+
Characterised bacterial strains in our reference library
9
Clinical or pre-clinical studies in active programmes
3.2M
Daily doses produced under GMP per year
14
International markets where Medalta is distributed
For partners
Build a microbiome programme with us.
Medalta partners with distributors, clinics and brands on white-label microbiome lines, regional registration and clinical co-development.